Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Mass Gen Hosp
Obstetrics & Gynecology
Dr. John O. Schorge, MD
|
|
Give Review
John O. Schorge works in the field of Obstetrics & Gynecology. He attended Vanderbilt University School of Medicine. He received awards:"America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Meaningful Use Stage 1 Certification", "Fellow (FACS)", "Super Doctor" and "Fellow (FACOG)". John Schorge is a published doctor as well. He has 92 publications published. The latest was: Racial disparities in survival in malignant germ cell tumors of the ovary. John O. Schorge is registered with Medicare.
Publications
- Racial disparities in survival in malignant germ cell tumors of the ovary.
- Racial disparities in treatment of high-grade endometrial Cancer in the medicare population.
- Gynecologic Oncologist as surgical consultant: Intraoperative consultations during general gynecologic surgery as an important focus of gynecologic oncology training.
- Adnexal mass in the PostMenopausal patient.
- Trends in the treatment of Uterine leiomyosarcoma in the medicare population.
- FDG PET-CT of gynecologic Cancers: pearls and pitfalls.
- Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy.
- Müllerian Adenosarcoma of the Uterus With Low-grade Sarcomatous Overgrowth Characterized by Prominent Hydropic Change Resulting in Mimicry of a Smooth Muscle Tumor.
- Clinical outcomes of women with recurrent or persistent Uterine leiomyosarcoma.
- Primary debulking surgery for advanced ovarian Cancer: Are you a believer or a dissenter?
- Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies.
- Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial Cancer: A SEER analysis.
- Transitional cell Carcinoma of the ovary: A case-control study.
- Mucinous AdenoCarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
- Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous Carcinoma of the ovary.
- Patient, treatment and discharge factors associated with hospital readmission within 30days after surgical cytoreduction for epithelial ovarian Carcinoma.
- Prognostic determinants in patients with uterine and ovarian clear cell Carcinoma: A SEER analysis.
- Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian Cancer.
- Racial disparities in Cervical cancer survival over time.
- Racial disparities and changes in clinical characteristics and survival for vulvar Cancer over time.
- Carcinosarcoma of the ovary compared to papillary serous ovarian Carcinoma: A SEER analysis.
- Atypical glandular cells.
- Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy Tube placement.
- Embryonal rhabdomyosarcoma of the Uterine corpus.
- Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian Carcinoma.
- Uterine papillary serous Cancer: A review of the literature.
- Prognostic determinants in patients with uterine and ovarian clear Carcinoma.
- Clear cell Carcinoma of the ovary: A review of the literature.
- Current surgical management of ovarian Cancer.
- Prognostic Determinants in Patients With Stage I Uterine Papillary Serous Carcinoma: A 15-Year Multi-Institutional Review.
- Carcinosarcoma of the ovary: A review of the literature.
- Primary Cytoreductive Surgery for Advanced Ovarian Cancer: Is it the Past, Present, or Future?
- Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer.
- Cytoreductive surgery for advanced ovarian Cancer: quo vadis?
- Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal Status.
- Evolution of surgical management of early-stage endometrial Cancer.
- Recurrent endometrial Cancer.
- Defining Prognostic Variables in Recurrent Endometrioid Endometrial Cancer: A 15-Year Single-Institution Review.
- Improved survival in non-Ashkenazi Jewish ovarian Cancer patients with BRCA1 and BRCA2 gene mutations.
- Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer.
- Carcinosarcoma of the ovary: A case-control study.
- CA125 screening after risk-reducing salpingo-oophorectomy: are the titers too high, or is it all just too much?
- Laparoscopic surgical staging of early ovarian Cancer.
- Single-incision laparoscopic staging for endometrial Cancer.
- Evidence for Cancer stem cells contributing to the pathogenesis of ovarian Cancer.
- Prognostic determinants in patients with stage IIIC and IV uterine papillary serous Carcinoma.
- SGO White Paper on ovarian Cancer: etiology, screening and surveillance.
- Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote Cancer cell proliferation.
- Mouse models of Uterine corpus tumors: clinical significance and utility.
- Surgical debulking of ovarian Cancer: what difference does it make?
- Somatic LKB1 mutations promote Cervical cancer progression.
- Differential roles of telomere attrition in type I and II endometrial carcinogenesis.
- Implications of EGFR inhibition in ovarian Cancer cell proliferation.
- Loss of Lkb1 provokes highly invasive endometrial adenoCarcinomas.
- Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian Cancer patients.
- Prospective determination of prevalence of lynch syndrome in young women with endometrial Cancer.
- Fertility-sparing surgery in 101 women with adenoCarcinoma in situ of the cervix.
- Simplifying the preevacuation testing strategy for patients with molar pregnancy.
- Gestational trophoblastic disease among Hispanic women: a 21-year hospital-based study.
- Retrospective cohort study of surgical staging for Ovarian low malignant potential tumors.
- Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal Carcinomas.
- Promoter hypermethylation profile of Ovarian epithelial neoplasms.
- Fertility-sparing surgery for Ovarian low malignant potential tumors.
- Duration of Human chorionic gonadotropin surveillance for partial hydatidiform moles.
- Management of cervical adenoCarcinoma in situ during pregnancy.
- BRCAPAP: feasibility of clinical BRCA testing on liquid-based Cervical cytology: implications for biomarker development.
- Surgical staging of Ovarian low malignant potential tumors.
- Osteopontin as an adjunct to CA125 in detecting recurrent ovarian Cancer.
- AdenoCarcinoma of the cervix.
- Aberrant p16 methylation is a biomarker for tobacco exposure in Cervical squamous cell carcinogenesis.
- P16 as a molecular biomarker of cervical adenoCarcinoma.
- Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenoCarcinoma.
- Primary abdominal gestational chorioCarcinoma.
- Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian Cancer.
- Postconization surveillance of cervical adenoCarcinoma in situ. A prospective trial.
- Management of low-risk gestational trophoblastic neoplasia in indigent women.
- Haptoglobin-alpha subunit as potential serum biomarker in ovarian Cancer: identification and characterization using proteomic profiling and mass spectrometry.
- Postmolar surveillance at a trophoblastic disease center that serves indigent women.
- Cervical adenoCarcinoma survival among Hispanic and white women: a multicenter cohort study.
- Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data.
- ThinPrep detection of cervical and endometrial adenoCarcinoma: a retrospective cohort study.
- Methylation profiles of sporadic Ovarian tumors and nonmalignant ovaries from high-risk women.
- Endocervical curettage at conization to predict residual cervical adenoCarcinoma in situ.
- Cytologic and biopsy findings leading to conization in adenoCarcinoma in situ of the cervix.
- Osteopontin as a potential diagnostic biomarker for ovarian Cancer.
- Early-stage cervical adenoCarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
- Stage IIB-IVB cervical adenoCarcinoma: prognostic factors and survival.
- Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome.
- Endometrial stromal sarcoma: a clinicopathologic study of 29 patients.
- Comparison of outcomes in patients with early-stage mucinous endometrial Cancer and those with endometrioid endometrial Cancer, with and without adjuvant therapy.
- Prognostic determinants in patients with uterine and Ovarian carcinosarcoma.
Schools
Vanderbilt University
Harvard Med School Brigham and Women39s HospMa Gen Hospital
Harvard Med SchBrigham and Women39s Hospital
Procedures Preformed
- Colpopexy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Adrenogenital Disorders
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Bronze Direct CACA IN HIX
- Pathway X Enhanced/Ind Guided Access ME
- Blue Card PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- GHI PPO
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Super Doctor
- Fellow (FACOG)
Education
-
Brigham and Women's Hospital -
Vanderbilt University School of Medicine
Hospital
-
Southern New Hampshire Medical Center -
Brigham and Women's Hospital -
Newton-Wellesley Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1669439923 | |
| NPPES Provider LastName | SCHORGE | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 175.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 7.43 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669439923 |
| Last Name Of The Provider | SCHORGE |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Neil S. Horowitz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jami A. Star, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Boruta II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rachel M. Clark, MD |
|
|
Dr. Isaac Schiff, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Steven J. Ralston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Young B. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald E. Iverson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelley Saia, MD
This Doctor is OpenDoctor Recommended.
|